Sg Americas Securities, LLC Unity Biotechnology, Inc. Transaction History

Sg Americas Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$2.94 - $12.43 $53,378 - $225,679	-18,156 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$5.28 - $9.67 $95,863 - $175,568	18,156 New	18,156 $158,000
Q2 2019 Jul 29, 2019	SELL	$7.59 - $10.21 $98,609 - $132,648	-12,992 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$7.65 - $16.66 $99,388 - $216,446	12,992 New	12,992 $105,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.